Consistent dosing-time dependent tolerability of everolimus (EV) in a pilot study in women with metastatic breast cancers (MBC) and in a mouse chronopharmacology investigation.
Yazar
Giacchetti, Sylvie
Espié, Marc
Chang-Marchand , Yunhua
Arrondeau, Jennifer
Machowiak, Jean
Cuvier, Caroline
Li, Xiao-Mei
ÖZTÜRK, Narin
OKYAR, Alper
Lévi, Francis
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]